These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9647358)
1. Receptor occupancy in myocardium, adrenal cortex, and brain by TH-142177, a novel AT1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect. Nozawa Y; Miyake H; Yamada S; Kimura R Pharm Res; 1998 Jun; 15(6):911-7. PubMed ID: 9647358 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist. Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Miyake H; Yamada S; Kimura R Fundam Clin Pharmacol; 1997; 11(5):395-401. PubMed ID: 9342592 [TBL] [Abstract][Full Text] [Related]
3. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
7. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats. Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Balla T; Baukal AJ; Eng S; Catt KJ Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513 [TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan. Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849 [TBL] [Abstract][Full Text] [Related]
12. AT1 receptor characteristics of angiotensin analogue binding in human synovium. Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862 [TBL] [Abstract][Full Text] [Related]
13. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Zhuo J; Song K; Abdelrahman A; Mendelsohn FA Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288 [TBL] [Abstract][Full Text] [Related]
14. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats. Bunting MW; Widdop RE Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794 [TBL] [Abstract][Full Text] [Related]
15. Influence of tissue freezing on the binding of 125I-sarcosine1, isoleucine8 angiotensin II to angiotensin II receptor subtypes in the rat. Lu XY; Zhang W; Grove KL; Speth RC J Pharmacol Toxicol Methods; 1995 Apr; 33(2):83-90. PubMed ID: 7766920 [TBL] [Abstract][Full Text] [Related]
16. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury. Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist. Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348 [TBL] [Abstract][Full Text] [Related]
18. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670 [TBL] [Abstract][Full Text] [Related]
19. Binding of valsartan to mammalian angiotensin AT1 receptors. de Gasparo M; Whitebread S Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935 [TBL] [Abstract][Full Text] [Related]
20. Receptor binding radiotracers for the angiotensin II receptor: radioiodinated [Sar1, Ile8]Angiotensin II. Gibson RE; Beauchamp HT; Fioravanti C; Brenner N; Burns HD Nucl Med Biol; 1994 May; 21(4):593-600. PubMed ID: 9234316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]